you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals

BSE Live

Apr 19, 14:02
579.90 8.00 (1.40%)
Volume
AVERAGE VOLUME
5-Day
436,384
10-Day
314,425
30-Day
167,309
579,380
  • Prev. Close

    571.90

  • Open Price

    572.00

  • Bid Price (Qty.)

    579.55 (60)

  • Offer Price (Qty.)

    579.90 (172)

NSE Live

Apr 19, 14:02
579.80 7.90 (1.38%)
Volume
AVERAGE VOLUME
5-Day
8,098,368
10-Day
5,350,010
30-Day
2,767,030
11,231,736
  • Prev. Close

    571.90

  • Open Price

    570.00

  • Bid Price (Qty.)

    579.80 (880)

  • Offer Price (Qty.)

    579.90 (172)

Financials

2020 2019 2018 2017 2016
Cash Flow of Glenmark Pharma (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 1,534.64 1,818.18 1,218.83 2,552.90 1,746.53  
Net CashFlow From Operating Activities 1,579.12 2,489.58 1,123.72 877.72 354.75  
Net Cash Used In Investing Activities -1,607.38 -2,255.61 -1,137.12 -2,580.29 -1,545.60  
Net Cash Used From Financing Activities -139.42 -155.11 -61.58 1,879.38 1,222.55  
Foreign Exchange Gains / Losses -0.02 0.08 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.15 -0.17 0.51  
Net Inc/Dec In Cash And Cash Equivalents -167.71 78.95 -74.84 176.64 32.23  
Cash And Cash Equivalents Begin of Year 255.00 176.05 250.88 74.24 42.02  
Cash And Cash Equivalents End Of Year 87.29 255.00 176.05 250.88 74.24  
Source : Dion Global Solutions Limited